These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 6350412

  • 1. [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
    Andermann C, Mialhe D, Arne JL, Vende D, Bec P.
    J Fr Ophtalmol; 1983; 6(4):367-74. PubMed ID: 6350412
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J, Sobecki R, Czechowicz-Janicka K, Kecik D, Kałuzny BJ, Stewart JA, Stewart WC.
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [Abstract] [Full Text] [Related]

  • 4. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T, Gross R, Pearson J, Rusk C, Adamsons I.
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [Abstract] [Full Text] [Related]

  • 5. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K, Snyder E, Adamsons I.
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D, Charlin JF, Cohn H, Dascotte JC, George JL, Lesure P, Massin M, Massin G, Maurin JF, Renard JP.
    J Fr Ophtalmol; 1995 Jul; 18(10):589-96. PubMed ID: 8568162
    [Abstract] [Full Text] [Related]

  • 7. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG.
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [Abstract] [Full Text] [Related]

  • 8. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y, Chen Z, Song J.
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [Abstract] [Full Text] [Related]

  • 9. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
    Robin AL.
    Trans Am Ophthalmol Soc; 1996 Dec; 94():89-101; discussion 101-3. PubMed ID: 8981691
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
    Ren J, Shin DH, Chung HS, Birt CM, Glover BK, Juzych MS, Hughes BA, Kim C.
    Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082
    [Abstract] [Full Text] [Related]

  • 11. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension.
    Kent AR, Vroman DT, Thomas TJ, Hebert RL, Crosson CE.
    J Glaucoma; 1999 Aug; 8(4):257-62. PubMed ID: 10464735
    [Abstract] [Full Text] [Related]

  • 12. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA, Polis A, Ostrov CS, Boyle JE.
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [Abstract] [Full Text] [Related]

  • 13. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
    Reis R, dos Santos LC, Vila MP, Magacho L.
    Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.